mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |